Skip to main content
  • 100 Accesses

Synonyms

MFS

Definition

Marfan syndrome is an autosomal dominant pleiotropic disorder of connective tissue with an incidence in the general population of approximately two to three in 10,000. There is no particular ethnic predisposition. The major clinical findings associated with Marfan syndrome include aortic root dilatation that may lead to dissection, ectopia lentis and dural ectasia (4).

Characteristics

Mitral valve prolapse, aortic root dilatation, mitral regurgitation, aortic valve regurgitation and dissection and rupture of the aorta are the most common cardiovascular findings in patients with Marfan syndrome. Additional ocular signs include myopia, increased axial globe length that may lead to retinal detachment and corneal flatness. Skeletal features, which may collectively represent a single major criteria and lead to earlier recognition of Marfan syndrome, include increased height and arm span, reduced upper to lower segment ratio, pectus excavatum or pectus carinatum,...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 799.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 799.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. De Paepe A, Devereux RB, Dietz HC et al (1996) Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62:417–426

    PubMed  CAS  Google Scholar 

  2. Dietz HC, Cutting GR, Pyeritz RE et al (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352:337–339

    PubMed  CAS  Google Scholar 

  3. Faivre L, Gorlin RJ, Wirtz MK et al (2003) In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J Med Genet 40:34–36

    PubMed  CAS  Google Scholar 

  4. Pyeritz RE, McKusick VA (1979) The Marfan syndrome: diagnosis and management. N Engl J Med 300:772–777

    PubMed  CAS  Google Scholar 

  5. Sakai LY, Keene DR, Engvall E (1986) Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 103:2499–2509

    PubMed  CAS  Google Scholar 

  6. Silverman DI, Burton KJ, Gray J et al (1995) Life expectancy in the Marfan syndrome. Am J Cardiol 75:157–160

    PubMed  CAS  Google Scholar 

  7. Whiteman P, Handford PA (2003) Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders. Hum Mol Genet 12:727–737

    PubMed  CAS  Google Scholar 

  8. Neptune ER, Frischmeyer PA, Arking DE et al (2003) Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33:407–411

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philip F. Giampietro .

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag

About this entry

Cite this entry

Giampietro, P.F. (2006). Marfan Syndrome. In: Encyclopedic Reference of Genomics and Proteomics in Molecular Medicine. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-29623-9_1830

Download citation

Publish with us

Policies and ethics